Europe’s biotechnology sector is entering a strong growth phase as countries expand pharmaceutical and biotech facilities and adopt advanced technologies such as AI, gene editing, genomics, and DNA sequencing. The sector was valued at USD 465.87 billion in 2025, is expected to reach USD 518.51 billion in 2026, and is projected to reach USD 1,358.99 billion by 2035, growing at a CAGR of 11.30% from 2026 to 2035.
The region benefits from strong research infrastructure, government funding, academic collaboration, and established biotechnology companies. Increasing chronic disease prevalence is also encouraging investment in targeted therapies, cell and gene therapies, and personalized medicine.
Key Trends
One of the most important trends is the increasing integration of artificial intelligence into biotechnology. AI is being applied to drug discovery, diagnosis, patient data analysis, and personalized treatment development. These capabilities can accelerate research and improve the identification of promising therapeutic candidates.
Gene editing and genomics are also advancing rapidly. Large-scale initiatives such as the Genome of Europe project are supporting genomic data collection, sequencing, and collaboration across European countries. CRISPR technology is gaining attention for applications in cancer research, genetic diseases, and regenerative medicine.
Investment is another major growth factor. Government programs, European funding initiatives, venture capital, and private investments are supporting biotech startups, research institutions, and innovative therapeutic platforms.
Segment Insights
Biopharmaceuticals held the largest share of 43% in 2025, supported by increasing demand for targeted biologics, gene therapies, and advanced treatments. Bioservices are expected to grow rapidly as pharmaceutical and biotechnology companies increasingly outsource research, development, manufacturing, and related activities.
By technology, DNA sequencing and genomics accounted for 27% in 2025. Meanwhile, CRISPR and gene editing are expected to expand rapidly as research progresses across therapeutic and agricultural applications.
Healthcare and medical biotechnology represented the largest application segment, with a 47% share in 2025. Industrial biotechnology is expected to experience strong growth as Europe increases its focus on sustainable production and bio-based solutions.
Pharmaceutical and biotechnology companies led the end-user segment with 45%, while CROs and CDMOs are expected to grow quickly because of increasing outsourcing and demand for specialized expertise.
Regional Outlook
Germany led Europe with a 22% share in 2025, supported by strong government investment, research infrastructure, and biotechnology development.
The Nordic countries are expected to record the fastest growth, supported by established biotech clusters, leading universities, research institutions, and strong collaboration between academia and industry.
Download a Sample Report: https://www.towardshealthcare.com/download-sample/6271
Future Outlook
The future of European biotechnology will be shaped by AI, CRISPR, genomics, cell and gene therapies, bioservices, bioinformatics, and sustainable biotechnology. Continued investment and collaboration should strengthen Europe’s position as a global center for biotechnology innovation.
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium